GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Silence Therapeutics plc (SLN) | 8/10/2026 7:33:44 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $106,412,000 | EPS -$0.09 | ||
| Silence Therapeutics plc (SLN) | 8/10/2026 7:21:21 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $0 | Assets $106,412,000 | EPS -$0.09 | Export Earnings Model | |
| Silence Therapeutics plc (SLN) | 5/7/2026 8:34:21 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $422,000 +197.2% | Assets $115,123,000 | EPS -$0.11 | |
| Silence Therapeutics plc (SLN) | 5/7/2026 8:17:59 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $422,000 +197.2% | Assets $115,123,000 | EPS -$0.11 | Export Earnings Model | |
| Silence Therapeutics plc (SLN) | 4/29/2026 4:33:15 PM | View | Proxy | SEC | Y 2025 | ||||||
| Silence Therapeutics plc (SLN) | 3/5/2026 8:05:31 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $559,000 -98.7% | Assets $131,442,000 | EPS -$0.63 | |
| Silence Therapeutics plc (SLN) | 3/5/2026 7:41:35 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $34,000 | Assets $131,442,000 | EPS -$0.09 | Export Earnings Model | |
| Silence Therapeutics plc (SLN) | 11/6/2025 8:07:02 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | ||||
| Silence Therapeutics plc (SLN) | 11/6/2025 7:40:08 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $159,000 | Assets $146,790,000 | EPS -$0.15 | Export Earnings Model | |
| Silence Therapeutics plc (SLN) | 8/7/2025 8:12:11 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | ||||
| Silence Therapeutics plc (SLN) | 8/7/2025 7:35:47 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $224,000 | Assets $165,233,000 | EPS -$0.19 | Export Earnings Model | |
| Silence Therapeutics plc (SLN) | 5/16/2025 6:06:45 AM | View | Proxy | SEC | Y 2024 | ||||||
| Silence Therapeutics plc (SLN) | 5/8/2025 8:45:38 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | ||||
| Silence Therapeutics plc (SLN) | 5/8/2025 8:10:55 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $142,000 | Assets $185,298,000 | EPS -$0.20 | Export Earnings Model | |
| Silence Therapeutics plc (SLN) | 4/30/2025 4:44:26 PM | Small | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $43,258,000 +36.7% | Assets $202,635,000 | EPS -$0.33 | |
| Silence Therapeutics plc (SLN) | 2/27/2025 4:44:58 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $43,258,000 +36.7% | Assets $202,635,000 | EPS -$0.33 | |
| Silence Therapeutics plc (SLN) | 2/27/2025 4:20:19 PM | View | Financials | Earnings | SEC | Y 2024 | Assets $202,635,000 | Export Earnings Model | |||
| Silence Therapeutics plc (SLN) | 3/13/2024 9:11:03 AM | Micro | View | Financials | 20-F | SEC | Y 2023 ending: 12/31/2023 | Rev: $31,643,000 +46.1% | Assets $119,448,000 | EPS -$0.49 | |
| Silence Therapeutics plc (SLN) | 3/15/2023 9:17:19 AM | Micro | View | Financials | 20-F | SEC | Y 2022 ending: 12/31/2022 | Rev: $21,655,000 +26.8% | EPS -$0.52 | ||
| Silence Therapeutics plc (SLN) | 3/17/2022 12:45:35 PM | Micro | View | Financials | 20-F | SEC | Y 2021 ending: 12/31/2021 | Rev: $17,083,040 +143.0% | |||
| Silence Therapeutics plc (SLN) | 4/29/2021 4:45:53 PM | Micro | View | Financials | 20-F/A | SEC | Y 2020 ending: 12/31/2020 | Rev: $7,029,557 +2,156.0% |